Skip to content

Influencing factors for the Serum FGF1 levels in newly diagnosed type 2 diabetes mellitus

Influencing factors for the Serum FGF1 levels in newly diagnosed type 2 diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15005977
Enrollment
Unknown
Registered
2015-02-12
Start date
2015-02-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

newly diagnosed type 2 diabetes mellitus

Interventions

T2DM subjects cohort:Nil
normal control cohort:Nil

Sponsors

Department of Endocrinology, Affiliated Hospital of Jiangsu University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. T2DM subjects: The criteria of diagnosis of type 2 diabetes recommended by WHO in 1999 were adopted, these newly diagnosed T2DM subjects had fasting plasma glucose levels >7.0mmol/L and 2h OGTT glucose levels >11.1mmol/L; 2. Normal control: healthy person.

Exclusion criteria

Exclusion criteria: T2DM subjects who were treated with oral hypoglycemic agents were excluded to avoid the possible confounding effects of anti-diabetic medications. T1DM, individuals with gestational diabetes, active hepatitis/liver cirrhosis, chronic renal failure on hemodialysis, congestive heart failure or other known major disease were precluded from the study.

Design outcomes

Primary

MeasureTime frame
FGF1;OGTT;insulin releasing test;blood lipid profiles;BMI;WHR;HbA1c;blood pressure;smoking habit;age;Gender;

Countries

China

Contacts

Public ContactYUAN Guo-yue
yuanguoyue@hotmail.com+86 13505289352

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026